M. Barissi

Systemic delivery of a CXCR4-CXCL12 signaling inhibitor encapsulated in synthetic protein nanoparticles for glioma immunotherapy

J. Lahann, Jason V. Gregory, P. Lowenstein, 2021, bioRxiv.

Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy.

J. Lahann, Jason V. Gregory, P. Lowenstein, 2022, ACS nano.

H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models

Jennifer S. Yu, S. Venneti, P. Lowenstein, 2022, The Journal of clinical investigation.